Biopix DNA Technology S.A.

25/04/2025

The world's deadliest creature isn't what you'd expect.

At BIOPIX-T, we are proud to mark World Malaria Day with the launch of the AmpliPan Malaria Test Kit — a cutting-edge diagnostic solution designed to support global efforts in the fight against malaria.

Our new test kit uses real-time colorimetric qcLAMP technology to detect the DNA of all five human-infecting Plasmodium species: P. falciparum, P. vivax, P. ovale (Curtis & Wallikeri), P. malariae, and P. knowlesi.

Compact, user-friendly, affordable and designed for rapid and accurate field deployment, the AmpliPan test kit includes all necessary components for easy sampling and analysis — empowering healthcare professionals worldwide.

BIOPIX-T’s AmpliPan Malaria Test Kit underscores our commitment to accessible, high-performance diagnostics in the global health landscape.

BIOPIX-T is proud to present validated performance data for the AmpliPan Malaria Test Kit:

· 100% specificity for Genomic DNA, Whole Blood & dried blood spots

· High sensitivity with 96.9% for Genomic DNA, 94.4% for WB and 97.2 for DBS

· Improved accuracy with 97.5% for Genomic DNA, 95.2% for WB and 97.7% for DBS

· Exceptional limit of detection with less than 10 parasitized cells/ul for genomic DNA, less than 25 for WB and less than 10 parasitized cells/ul for DBS.

This level of diagnostic accuracy empowers health professionals with rapid, reliable, and field-deployable tools to fight malaria, especially in endemic and resource-limited settings.

A world without malaria is possible - through innovation, collaboration, and unwavering commitment.

Let’s continue pushing boundaries in diagnostics to protect the most vulnerable and save lives.

12/02/2025

🚀 Exciting news from Heraklion, Greece! The DxHub consortium bringing together Greek and Portuguese innovation ecosystems has officially kicked off at FORTH with a dynamic and inspiring meeting.
With a strong quadruple helix collaboration, we’re setting the stage for impactful milestones ahead:
✅ Defining strategies and goals to drive our mission forward
✅ Launching innovative R&I projects in infectious disease diagnostics
✅ Engaging and empowering Science Citizens in our work
DxHub, a HORIZON WIDERA Excellence Hub, is dedicated to advancing point-of-care diagnostic solutions for infectious diseases, addressing cross-border health threats through cutting-edge innovation.
A huge thank you to our incredible partners for their commitment and vision:
Foundation for Research and Technology - Hellas (FORTH), ITQB NOVA, IHMT NOVA, University of Crete, BIOPIX DNA TECHNOLOGY S.A., STABVIDA Bioinformática, EnzyQuest, ΒΙΟΕΡΕΥΝΗΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ Α.Ε., P-BIO - Associação Portuguesa de Bioindústria, Câmara Municipal de Oeiras, REGION OF CRETE, National Public Health Organization, GREECE, Technical Institute of Heraklion Chamber, Aepa, Metavallon VC, Instituto Nacional de Investigação Agrária e Veterinária, IP (INIAV, IP)

Looking forward to the journey ahead! 🌍🔬

15/01/2025

Proud partners of the UniHealth EU project, shaping the future of pandemic preparedness.

20/12/2024

As the year draws to a close, we want to take a moment to extend our heartfelt gratitude to all our partners, clients, and team members who have supported us throughout this year.

This holiday season, we’re reminded of the importance of health, innovation, and collaboration in everything we do. 🎄

At BIOPIX-T, we remain committed to improving lives through cutting-edge medical technology and patient-focused solutions.

Wishing you and your loved ones a joyful, peaceful, and healthy Christmas! 🎁✨

Here’s to an exciting and innovative year ahead in 2025. 🎉

20/12/2024

🌍 Celebrating Success: Positive Evaluation of the ResTick Project 🌟

BIOPIX-T is thrilled to announce the successful evaluation of the ResTick project, led by Kotsyfakis Michail and the Foundation for Research and Technology - Hellas (FORTH) where we proudly serve as a partner in this transformative research consortium!

ResTick focuses on addressing the urgent challenges posed by ticks as disease vectors, particularly in combating the Crimean-Congo Haemorrhagic Fever (CCHF) in Sub-Saharan Africa (SSA). As climate change reshapes ecosystems and amplifies disease risks, the need for innovative and proactive solutions has never been greater.

🎯 Key Objectives of ResTick:

✅ Develop early warning and monitoring systems for ticks and tick-borne diseases.
✅ Create affordable, user-friendly diagnostic tools for point-of-care applications.
✅ Establish predictive models for tick abundance and disease prevalence.
✅ Build a dedicated network for studying tick species, pathogens, and interactions in SSA.

By leveraging advanced molecular ecology, cutting-edge technologies, and interdisciplinary collaboration across molecular biology, veterinary science, epidemiology, and diagnostic assay development, ResTick is pioneering One Health approaches to safeguard public health and enhance resilience against tick-borne diseases.



INSTITUT NATIONAL DE SANTE PUBLIQUE - BURKINA FASO (INSP-BF)
Université Alassane Ouattara Côte d'Ivoire
Universite D'Abomey-Calavi Benin
Université de Lomé Togo
Addis Ababa University Ethiopia
Makerere University Uganda
Kiara Health (Pty) Ltd South Africa

27/11/2024

On World Olive Day, BIOPIX-T has developed a field-deployable method for real-time detection of V. dahliae in olive trees based on a integrated with its flagship device.

Starting from and with minimal sample preparation, BIOPIX-T's method can detect trees infected with V. dahliae with and in just 35 min, without the need for technical expertise and specialized equipment.

The method is highly simplified incorporating just one pre-amplification step before transfer to the ; the ability to obtain real-time results on a tablet combined with the capability for and to a decision-making center provides promising alternative to currently used laboratory-based diagnostic methods.

25/11/2024

30/10/2024

Biopix DNA Technology S.A. is thrilled for Patras Medicine iGEM 2024 team reaching the TOP 10 finalists in the undergraduate category in the iGEM Competition Grand Jamboree, the biggest Synthetic Biology Competition in the world!

Patras Medicine iGEM team’s therapeutic focus targeting Alzheimer’s disease competed with innovative projects across diverse fields - from Space and AI to Oncology, Diagnostics, and Fashion & Cosmetics.

The team won the GOLD MEDAL as well as the INCLUSIVITY AWARD and was nominated for Best Therapeutic Project ranked in the top 5.

As Patras Medicine iGEM 2024 team’ s sponsors we are delighted we stepped in at a critical moment of the team’s journey to bring their ideas to life in the lab.

Congratulations from BIOPIX-T to each member of the team for your collective effort and success!!

16/10/2024

03/10/2024

BIOPIX DNA TECHNOLOGY S.A. optimized Universal Mastermix contains all the required for the performance of real-time -mediated ( ) analysis of or samples. Only primers and the template for the target should be added.

The Universal Mastermix is open access and easily to suit your and needs.

It is designed to be used on a wide range of applications; from the of , and as well as to an even wider spectrum of diseases, such as and using directly into the reaction different kinds of samples such as blood, swabs, urine, etc.

It is one of the most and combination on the market globally which can be used alongside our flagship BIOPIX-T as well as machines.

Purchase now at [email protected] (Tel: +30 28 10 39 19 85).

27/09/2024

BIOPIX-T’s flagship diagnostic device for Research Use Only is now also available on .

https://apps.apple.com/gr/app/pebble-ruo/id6670613786

Check out new features and a refined user experience.

Download for quick, reliable diagnostics wherever you are.

17/09/2024

is the most important wilt of with a broad host range causing devastating diseases currently without any effective chemical control. Traditional detection methodologies are based on symptoms-observation or lab-detection using time consuming culturing or molecular techniques.

BIOPIX-T’s can be used as a field-deployable for the real-time of V. dahliae in olive trees based on a protocol. Starting from crude olive tree wood and with minimal sample preparation, PEBBLE can detect trees infected with V. dahliae with and in just 35 min, without the need for technical expertise and specialized equipment.

The method is highly incorporating just one pre-amplification step before transfer to the device; the ability to obtain real-time on a tablet combined with the capability for and to a decision-making provides promising to currently used laboratory-based .

The of a with coupled with a real-time LAMP platform without the need to extract purified DNA from the samples, as evaluated in the important wilt pathogen V. dahliae in olive, lays the ground for on-site of .

You can read our paper, on Plant Methods 20, 139 (2024). https://doi.org/10.1186/s13007-024-01251-x

IMBB Institute of Molecular Biology and Biotechnology
for Research and Technology – Hellas (FORTH)
Department University of Crete
Biosensors Group
University of Athens
ΕΛΓΟ ΔΗΜΗΤΡΑ - ELGO Dimitra
Ελληνικό Μεσογειακό Πανεπιστήμιο - Hellenic Mediterranean University

Background Verticilium dahliae is the most important wilt pathogen of olive trees with a broad host range causing devastating diseases currently without any effective chemical control. Traditional detection methodologies are based on symptoms-observation or lab-detection using time consuming culturi...